ABC Share Price Performance
Recent ABC News & Updates
No updates
Abcam plc Key Details
Last Reported Earnings
Jun 30, 2022
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- 0.032
- Gross Margin
- 74.34%
- Net Profit Margin
- 2.08%
- Debt/Equity Ratio
- 16.4%
Abcam plc Competitors
About ABC
- Founded
- 1998
- Employees
- 1682
- CEO
- WebsiteView website
Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include cytokines; edited cell lines and lysates; and various other products, including cellular activity kits, miRNA kits, biochemicals, and cell signaling pathway tools. The company serves scientists and researchers in academic institutions and research institutes, as well as in pharmaceutical, biotechnology, and diagnostics companies. It has operations in the Americas, Europe, the Middle East, Africa, China, Japan, and rest of the Asia Pacific. The company sells its products online. Abcam plc was incorporated in 1998 and is headquartered in Cambridge, the United Kingdom.
U.K. Market Performance
- 7 Days: -2.5%
- 3 Months: 17.1%
- 1 Year: 12.4%
- Year to Date: 12.2%
Over the last 7 days, the market has dropped 4.2%, driven by a loss of 5.7% in the Energy sector. In the last year, the market is actually up 7.7%. Earnings are forecast to grow by 14% annually. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading